Skip to main content

Nonprofit · EIN 22-3067246

NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC

Tax-exempt · FLEMINGTON, NJ 08822

Financials

$151K$98K2023$390K$100K2024
Revenue Expenses · by fiscal year end
Financials of NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$390,453$100,468$289,985$1,231,547$351,555$879,992
December 31, 2023990$151,460$98,040$53,420$1,051,896$461,889$590,007
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$504,615
Program service revenue
$0
Investment income
$21,783
Net income from fundraising events
-$135,945
Other revenue
-$135,945

Expenses

Grants and similar amounts paid
$56,000
Compensation of officers, directors and key employees
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Accounting fees
$20,206
Depreciation
$108
Program services (functional)
$56,000
Management and general (functional)
$44,468

Balance sheet and other

Total assets, start of year
$1,051,896
Total assets, end of year
$1,231,547
Total liabilities, end of year
$351,555
Net assets, end of year
$879,992
Net assets without donor restrictions
$879,992
Gross receipts
$526,399
Employees
0
Year formed
1990
State of legal domicile
NJ

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
DON GRIFFINDirector
Trustee or director
1$0
LAURA JOHNSONDirector
Trustee or director
1$0
ROBERT A FACCHINAPresident
Officer
1$0
JEFFREY A WESTTreasurer
Officer
1$0
990 for the year ended December 31, 2023: 4 people
NameTitleHours / weekCompensation
DON GRIFFINDirector
Trustee or director
1$0
LAURA JOHNSONDirector
Trustee or director
1$0
ROBERT A FACCHINAPresident
Officer
1$0
JEFFREY A WESTTreasurer
Officer
1$0

Address and contacts

Address (IRS master file)
PO BOX 272, FLEMINGTON, NJ 08822-0272
Principal officer (990 for 2024)
ROBERT A FACCHINA
Signed the 990
ROBERT A FACCHINA, President
Phone
(908) 788-2200
Return prepared by
THE BARSON GROUP PA

Mission

TO PROVIDE GRANTS TO SECTION 501C3 ORGANIZATIONS THAT ADVANCE AND IMPROVE SCIENTIFIC RESEARCH IN IMMUNOTHERAPY AND TO ORGANIZATIONS THAT PROMOTE, ADVANCE AND IMPROVE EDUCATION AND SUPPORT CANCER PATIENTS

990 for the year ended December 31, 2024

Program accomplishments

  • ALL OTHER ACCOMPLISHMENTS TO PROVIDE FUNDS FOR SERVICES TO PROGRAMS THAT SUPPORT INDIVIDUALS WITH CANCER, SUPPORTING SERVICES FOR INDIVIDUALS WITH CANCER, AND RESEARCH FOR CANCER
    Expenses $56,000 · grants $56,000
  • TO PROVIDE GRANTS TO FUND CAMPS AND OTHER SERVICES FOR CHILDREN WITH CANCER. THE HOLE IN THE WALL GANG - JULY 2020, A $1,000,000 GRANT COMMITMENT WAS MADE. THE GRANT WAS RECORDED ON THE 2020 RETURN. THE GRANT IS BEING PAID OVER AN 8 YEAR PERIOD YEARS 2020 THROUGH 2027 OF $125,000 PAID ANNUALLY

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
22-3067246
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1990
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$1,231,547
Income (IRS master file)
$526,399

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$390,453$100,468$1,231,547XML
990December 2023$151,460$98,040$1,051,896XML
990December 2022$4,423$136,357$1,104,751IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 22-3067246).

Questions about NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC

What is the EIN of NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC?
The employer identification number (EIN) of NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC is 22-3067246.
Is NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1990.
Are donations to NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC?
The 990 for the year ended December 31, 2024 names ROBERT A FACCHINA.
Who are the officers and directors of NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC?
The 990 for the year ended December 31, 2024 lists 4 people; 0 received compensation from the organization.
How much revenue does NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $390,453, expenses of $100,468 and total assets of $1,231,547 at year end.

Other nonprofits in FLEMINGTON

All nonprofits in FLEMINGTON · New Jersey · Medical research